Drug
Suvratoxumab
Suvratoxumab: highest development phase Phase 3, developed by Aridis Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Aridis Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| Suvratoxumab NCT05331885 | Phase 3 | Ventilator Associated Pneumonia |
Latest
No recent events.
Follow Suvratoxumab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.